A novel use of neoadjuvant crizotinib for a rare ALK-positive endobronchial tumor. 

 -  2019 
<br/><br/><label>Index Terms--Occupation: </label><br/>Medicine/Pulmonary/Critical Care<br/>MedStar Georgetown University Hospital Residents
<br/><br/><label>Index Terms--Curriculum Objective: </label><br/>Poster presented at